MLCL — Molecule Holdings Share Price
0.000.00%
Last trade - 00:00- CA$0.49m
- CA$6.18m
- CA$1.97m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.29 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -128.71% | ||
Financial Summary
| Year End 31st Oct | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | 0.46 | 1.97 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Molecule Holdings Inc. is a Canada-based licensed producer engaged in creating cannabis-infused beverages (CIBs) for the Canadian market. The Company operates through one segment being the production and co-packing CIBs. The Company produces drinks to provide opportunity and choice for people seeking a convenient and social way to consume cannabis. Its brands include PHRESH, embody, CANAJO and KLON. It is also focused on growing both its portfolio, and the overall cannabis beverage market.
Directors
- Andrew Audet CHM
- Philip Waddington PRE
- Jeff Stoss CFO
- Amy Proulx IND
- David Reingold IND
- Lindsay Weatherdon IND
- Last Annual
- October 31st, 2022
- Last Interim
- July 31st, 2023
- Incorporated
- May 19th, 2004
- Public Since
- April 10th, 1997
- Sector
- Beverages
- Industry
- Consumer Defensives
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 97,781,903
- Address
- 591 Reynolds Rd, LANSDOWNE, K0E 1L0
- Web
- https://molecule.ca/
- Phone
- +1 6132412332
- Auditors
- McGovern Hurley LLP
Upcoming Events for MLCL
Q4 2023 Molecule Holdings Inc Earnings Release
Q2 2024 Molecule Holdings Inc Earnings Release
Similar to MLCL
bettermoo(d) Food
Canadian Securities Exchange
BevCanna Enterprises
Canadian Securities Exchange
Centr Brands
Canadian Securities Exchange
HYTN Innovations
Canadian Securities Exchange
Koios Beverage
Canadian Securities Exchange
FAQ
What is the Molecule Holdings share price?
As of Today at 19:14 UTC, shares in Molecule Holdings are trading at CA$0.01. This share price information is delayed by 15 minutes.
How has the Molecule Holdings share price performed this year?
Shares in Molecule Holdings last closed at CA$0.01 and the price had moved by -75% over the past 365 days. In terms of relative price strength the Molecule Holdings share price has underperformed the Toronto Stock Exchange 300 Composite Index by -76.51% over the past year.
What are the analyst and broker recommendations for Molecule Holdings?
There is no consensus recommendation for this security.
What is the Molecule Holdings dividend yield?
Molecule Holdings does not currently pay a dividend.
Does Molecule Holdings pay a dividend?
Molecule Holdings does not currently pay a dividend.
When does Molecule Holdings next pay dividends?
Molecule Holdings does not currently pay a dividend.
How do I buy Molecule Holdings shares?
To buy shares in Molecule Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Molecule Holdings?
As of the previous close price of CA$0.01, shares in Molecule Holdings had a market capitalisation of CA$0.49m.
Where are Molecule Holdings shares listed?
Here are the trading details for Molecule Holdings:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: MLCL
What kind of share is Molecule Holdings?
Based on an overall assessment of its quality, value and momentum Molecule Holdings is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Molecule Holdings share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Molecule Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Molecule Holdings. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -55.2%.
As of the last closing price of CA$0.01, shares in Molecule Holdings were trading -76.88% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Molecule Holdings PE Ratio?
The Molecule Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Molecule Holdings?
Molecule Holdings' management team is headed by:
- Andrew Audet - CHM
- Philip Waddington - PRE
- Jeff Stoss - CFO
- Amy Proulx - IND
- David Reingold - IND
- Lindsay Weatherdon - IND